51 /100
HIGH RISK
Score updated Apr 13, 2026

CHRS

Coherus Oncology, Inc. — Stock Dilution Tracker

Track CHRS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track CHRS — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
42%
🔁 Convertible Conversion 60%
• Major convertible overhang: 32% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 30%
• 50-day avg $1.79 approaching $1 threshold
💰 Capital Raise 18%
• Active ATM program with $50M remaining capacity
🔔 Track CHRS — Get forecast alerts →
💹 Market Data
Market Cap$251.82M
Shares Outstanding149.89M
Float134.25M
Cash$172.12M
Debt$54.36M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 3.7% shares (2025Q4 vs prior)
127 institutional holders · 52.49M shares
#1 BlackRock, Inc. 10.56M shares
#2 VANGUARD GROUP INC 10.03M shares
#3 Kohlberg Kravis Roberts & Co. L.P. 3.04M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest28.14M
Days to Cover20.7
% of Float20.9%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2021
xbrl XBRL WARRANT Dec 31, 2014
8-K 8K EVENT Feb 17, 2026
424B5 ATM Feb 13, 2026
424B5 ATM Feb 12, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track CHRS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CHRS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required